Unconventional strategy could be the future: From target to KRAS broad range treatment
The RAS gene family comprises genes that regulate cell growth and differentiation. KRAS, a member of this family, is often mutated in different cancers, resulting in uncontrolled cell growth and tumor development. Recent clinical trial results on KRAS inhibition in NSCLC have defined the presence of...
| Published in: | Heliyon |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-05-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024057700 |